Key result
ZC3H10 represses type I interferon responses via ISG promoter binding, increasing viral infection susceptibility.
Why the study?
Precise regulation of type I interferon responses is critical to prevent pathological inflammation and autoimmunity, but the molecular mechanisms restraining IFN signaling remain incompletely defined.
Answers are grounded in this paper and cite their sources.
ZC3H10 is identified as a critical negative regulator of type I interferon signaling that represses ISG promoters to balance antiviral immunity.
Type I interferons (IFNs) play a central role in antiviral immunity by activating the JAK-STAT signaling pathway to induce interferon-stimulated genes (ISGs). Precise regulation of this response is critical to avoid pathological inflammation and autoimmunity, but the molecular mechanisms that restrain IFN signaling remain incompletely defined. Here, we performed a human whole-genome cDNA library screen and identified ZC3H10 as a negative regulator of the type I IFN response. Overexpression of ZC3H10 suppressed ISG expression following IFNβ stimulation and increased susceptibility to infection by Newcastle disease virus, human rhinovirus 16, Enterovirus A71, and SARS-CoV-2, whereas genetic deletion of ZC3H10 enhanced ISG expression and antiviral resistance. Mechanistically, ZC3H10 required nuclear localization, a functional nucleic acid-binding domain, and its coiled-coil domain to exert its inhibitory function. Furthermore, chromatin immunoprecipitation assays revealed that ZC3H10 directly binds to the TTTC motif within ISG promoters, thereby preventing their activation. Together, these findings establish ZC3H10 as a critical negative regulator of IFN signaling that functions to balance antiviral immunity.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied Viral infection. ZC3H10 overexpression or genetic deletion vs. Control was evaluated on Interferon-stimulated gene (ISG) expression and susceptibility to viral infection. ZC3H10 acts as a critical negative regulator of the type I interferon response by directly binding to ISG promoters and repressing their activation, thereby increasing susceptibility to viral infection.
Synapse has enriched 10 related papers. Consider them for comparative context: